The Veterinary Vaccines Except for Foot and Mouth market in Canada experienced a notable decline from 2013 through 2016, with the market value decreasing from 353.55 million USD to 240.66 million USD. A modest recovery between 2017 and 2020 followed, with market values stabilizing around the 290 million USD mark. By 2023, the market stood at 285.57 million USD. Year-on-year fluctuations have been mild, typically less than 1% declines in recent years. Over the last five years, the compound annual growth rate was 1.99%, indicating a slow recovery in the market.
Looking ahead, potential trends in the Canadian veterinary vaccine market include technological advancements in vaccine formulation, increased pet ownership driving demand, and heightened awareness about animal welfare. Economic conditions and regulatory changes could influence the market moving forward. Monitoring these factors will be crucial for understanding future market shifts.
